Health Technology Assessment: new opportunity to apply for Joint Scientific Consultations

On 23 September, the Commission will open the fourth request period for joint scientific consultations (JSCs) for 2026. 

JSCs enable health technology developers to consult on the planning of their health technology and how clinical studies should be conducted to best prepare for a subsequent Joint Clinical Assessment. A health technology developer can request JSCs for products that are likely to be subject of joint clinical assessment pursuant to Article 7(1) of the HTA regulation.

The submission period is open from 23 September to 21 October 2026 to developers of both medicinal products and medical devices (for medical devices classified as class IIb or III and in vitro diagnostics classified as class D).

Developers can apply for the following consultation slots during the request period: 

Requests must be uploaded to the HTA IT Platform by 21 October 2026. As access to the platform can take a few days, early registration is recommended. Check the dedicated webpage on how to submit a request.

Find out more:

• Factsheet on joint scientific consultations for medicinal products
• Guidance for selection of medicinal products and of medical devices and in vitro diagnostics for joint scientific consultations
• Health Technology Assessment